...
首页> 外文期刊>Clinical otolaryngology: official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery >An evaluation of the quality of evidence available to inform current bone conducting hearing device national policy
【24h】

An evaluation of the quality of evidence available to inform current bone conducting hearing device national policy

机译:评估可用于通知当前骨骼的证据质量,以通知当前骨骼进行听证会议国家政策

获取原文
获取原文并翻译 | 示例

摘要

Objectives: In 2016, NHS England published the commissioning policy on Bone Conducting Hearing Devices (BCHDs). This policy was informed by updated evidence on the clinical and cost-effectiveness of BCHDs as well as by the 2013 Bone Anchored Hearing Aid (BAHA) policy. Commissioning policies set the criteria for service delivery and therefore have a major impact on the care received by patients. It is important that stakeholders have a good appreciation of the available evidence informing policy, as this will promote engagement both with the policy and with future research leading on from the policy. In this article, we provide stakeholders with a transparent and pragmatic assessment of the quality of the body of evidence available to inform current BCHD national policy.
机译:目标:2016年,NHS英国发表了骨骼导电听力装置(BCHDS)的调试政策。 通过更新的证据了解这项政策,就BCHDS的临床和成本效益以及2013年骨骼锚定助听器(巴哈)政策提供了通知。 调试政策设定服务交付标准,因此对患者收到的护理产生重大影响。 重要的是,利益攸关方对可用的证据提供了良好的欣赏信息,因为这将促进与政策和未来的研究领导政策的参与。 在本文中,我们为利益攸关方提供了对可用于通知当前BCHD国家政策的证据质量的透明和务实评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号